Delayed payments to pharma MSMEs: A major challenge
Delayed payments put SMEs at a disadvantage compared to large size counterparts, inhibiting their ability to compete effectively…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Lupin gets US FDA approval for Doxycycline Hyclate Delayed-Release Tablets USP
This product will be manufactured at Lupin’s Pithampur facility in India
Our collaborations with Govt of India focus on building resilient healthcare systems
Sylvia Varela, AVP Asia Area, AstraZeneca discusses about the company’s plans to drive market growth, address public health…
Novo Nordisk to acquire Inversago Pharma for up to $1.075 bn
The acquisition of Inversago includes the company’s lead development asset INV-202, an oral CB1 inverse agonist
Sigachi Industries forays into API business, acquires majority stake in Trimax Bio Sciences
The API unit is approved by USFDA for advanced and critical intermediates
Dr Reddy’s Laboratories launch Saxagliptin and Metformin Hydrochloride ER tablets in US
Saxagliptin and metformin hydrochloride ER tablets are indicated as an adjunct to diet and exercise to improve glycemic control in…
UPS Healthcare launches UPS Premier service across India
Indian customers will have access to UPS Premier Gold service benefits, including “first-in, first-off” prioritisation, built-in…
Boehringer Ingelheim launches NexGard (afoxolaner) Small and Medium in India
NexGard is indicated for use in dogs and puppies from eight weeks of age and is delivered as a monthly treatment in highly…
NASH market holds enormous untapped potential: GlobalData
Currently, Madrigal’s resmetirom (selective thyroid hormone receptor-β agonist; THR-Beta agonist) will most likely be the first…
CEPI to support development of selfamplifying mRNA vaccine technology for use against Disease X
CEPI will provide up to $3.6 million to support the optimisation of the saRNA-platform technology, the production process, and…
Dyslipidemia market to grow to $15.53 bn in 2032 across 7MM: GlobalData
Growth will be driven by the launch of therapies with promising efficacies and new mechanism of actions, as well as the growth of…
WHO flags Cold Out cough syrup over higher limits of diethylene and ethylene glycol
The batch had 0.25 per cent of diethylene glycol and 2.1 per cent of ethylene glycol, when the acceptable safety limit for both is…
Marksans announces completion US FDA PADE inspection
The inspection was conducted at its Goa, Verna manufacturing facility from July 31, 2023 to August 4, 2023
Daiichi Sankyo will remain dominant in ADC market for oncology treatments: GlobalData
By 2029, the global market for ADC therapies in oncology is expected to be worth more than $36 billion
USFDA inspection at Solara’s Cuddalore facility concludes with Zero 483 observations
USFDA inspected the Cuddalore facility between July 31, 2023 – August 04, 2023
India is a key market for the company’s global plans
Vikrant Shrotriya, CVP & MD, Novo Nordisk India in an interaction with Express Pharma growth opportunities in pharma sector…
Granules Pharma completes USFDA PADE Inspection with zero observations
The inspection was conducted at Granules Pharmaceuticals from July 31, 2023 to August 03, 2023
Zydus gets USFDA approval for Indomethacin suppository with CGT designation
The company has been granted 180-day CGT exclusivity to market this product
Supriya Lifescience, Plasma Nutrition to collaborate for protein technology
During the term of the agreement, Supriya Lifescience will lead the manufacturing and marketing of ioProtein in India
Lupin US FDA approval for Fluocinolone Acetonide Topical Oil
This product will be manufactured at Lupin’s Somerset facility in the US